Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000810
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
1999-11-02
Brief Title:
Randomized Phase III Dose-Ranging Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate DLV U-90152S
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID